Financials
Income statement
Fiscal date | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
---|---|---|---|---|
Total reported revenue | 11.7B | 10.0B | 11.1B | 13.8B |
Cost of revenue | 5.7B | 5.1B | 5.0B | 5.5B |
Gross profit | 6.0B | 4.9B | 6.2B | 8.3B |
Operating expense | ||||
Research & development | 1.7B | 1.6B | 1.5B | 1.4B |
Selling general and admin | 4.3B | 3.7B | 4.1B | 3.8B |
Other operating expenses | -3.9B | 3.7B | 599M | 225M |
Operating income | 3.5B | -3.8B | 525M | 3.1B |
Non operating interest income | ||||
Income | 114M | 150M | 95M | 161M |
Expense | 385M | 642M | 682M | 648M |
Other income expense | — | — | — | — |
Pretax income | -481M | -4.3B | -97M | 2.6B |
Tax provision | -153M | -153M | -71M | 589M |
Net income | -328M | -4.2B | -26M | 2.0B |
Basic EPS | — | -4.3 | 0.0 | 2.0 |
Diluted EPS | — | -4.3 | 0.0 | 2.0 |
Basic average shares | — | 982.4M | 982.4M | 982.4M |
Diluted average shares | — | 982.4M | 982.4M | 982.4M |
EBITDA | 1.7B | 1.1B | 1.7B | 4.4B |
Net income from continuing op. | -328M | -4.2B | -26M | 2.0B |
Minority interests | -7M | 11M | -8M | -2M |
Preferred stock dividends | 0 | 0 | 0 | 0 |